Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut–Brain Axis

Cellular and Molecular Gastroenterology and Hepatology

Volumn 11, Issue 1, 2021, Pages 221-248

  Engevik, Melinda A ^a,b   Luck, Berkley ^a,b   Visuthranukul, Chonnikant ^a,b,c   Ihekweazu, Faith D ^a   Engevik, Amy C ^d   Shi, Zhongcheng ^a,b   Danhof, Heather A ^a   Chang Graham, Alexandra L ^a   Hall, Anne ^a,b   Endres, Bradley T ^e   Haidacher, Sigmund J ^a,b   Horvath, Thomas D ^a,b   Haag, Anthony M ^a,b   Devaraj, Sridevi ^a,b   Garey, Kevin W ^e   Britton, Robert A ^a   Hyser, Joseph M ^a   Shroyer, Noah F ^a   Versalovic, James ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF HOUSTON   (United States)

Author keywords

Bifidobacterium; Enterochromaffin Cells; Enteroids; Free Fatty Acid Receptor (FFAR)2; Organoids; Probiotics; Serotonin; Serotonin Transporter; Short Chain Fatty Acids (SCFAs)

Indexed keywords

AGAR; COMPLEMENTARY DNA; FREE FATTY ACID RECEPTOR 2; G PROTEIN COUPLED RECEPTOR; GENOMIC DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROBIOTIC AGENT; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SHORT CHAIN FATTY ACID; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG; ACETIC ACID;

ADULT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTEROIDES OVATUS; BEHAVIOR CHANGE; BIFIDOBACTERIUM; BIFIDOBACTERIUM DENTIUM; BRAIN TISSUE; CELL VIABILITY; COLON TISSUE; COLONY FORMING UNIT; COMMENSAL; COMPARATIVE STUDY; CONTROLLED STUDY; DESCENDING COLON; DNA EXTRACTION; ENTEROCHROMAFFIN CELL; ENTEROID; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GNOTOBIOTICS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE INNERVATION; INTESTINE TISSUE; LARGE INTESTINE; LS174T CELL LINE; MALE; MARBLE BURYING TEST; MASS SPECTROMETRY; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SCANNING ELECTRON MICROSCOPY; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; TERMINAL ILEUM; ANIMAL; ANIMAL MODEL; CELL CULTURE TECHNIQUE; GERMFREE ANIMAL; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; ORGANOID; PHYSIOLOGY;

ACETATES; ANIMALS; BEHAVIOR, ANIMAL; BIFIDOBACTERIUM; BRAIN-GUT AXIS; CELL CULTURE TECHNIQUES; ENTEROCHROMAFFIN CELLS; GASTROINTESTINAL MICROBIOME; GERM-FREE LIFE; HOST MICROBIAL INTERACTIONS; HUMANS; INTESTINAL MUCOSA; MICE; MODELS, ANIMAL; ORGANOIDS; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 85096186149     PISSN: None     EISSN: 2352345X     Source Type: Journal    
DOI: 10.1016/j.jcmgh.2020.08.002     Document Type: Article

References (152)

1. Ley, R.E., Peterson, D.A., Gordon, J.I., Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006), 837–848.
2. O'Hara, J.R., Skinn, A.C., MacNaughton, W.K., Sherman, P.M., Sharkey, K.A., Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol 8 (2006), 646–660.
3. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D.R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, J., Lepage, P., Bertalan, M., Batto, J.M., Hansen, T., Le Paslier, D., Linneberg, A., Nielsen, H.B., Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Li, S., Jian, M., Zhou, Y., Li, Y., Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak, S., Dore, J., Guarner, F., Kristiansen, K., Pedersen, O., Parkhill, J., Weissenbach, J., MetaHIT Consortium, Bork, P., Ehrlich, S.D., Wang, J., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
4. Gershon, M.D., 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 20 (2013), 14–21.
5. Resnick, R.H., Gray, S.J., Distribution of serotonin (5-hydroxytryptamine) in the human gastrointestinal tract. Gastroenterology 41 (1961), 119–121.
6. Gershon, M.D., Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 13:Suppl 2 (1999), 15–30.
7. Erspamer, V., Occurrence of indolealkylamines in nature. 1966, Springer-Verlag, New York.
8. Kim, J.J., Khan, W.I., 5-HT7 receptor signaling: improved therapeutic strategy in gut disorders. Front Behav Neurosci, 8, 2014, 396.
9. Bertrand, P.P., Barajas-Espinosa, A., Neshat, S., Bertrand, R.L., Lomax, A.E., Analysis of real-time serotonin (5-HT) availability during experimental colitis in mouse. Am J Physiol Gastrointest Liver Physiol 298 (2010), G446–G455.
10. Gershon, M.D., Tack, J., The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132 (2007), 397–414.
11. Hoffman, J.M., Tyler, K., MacEachern, S.J., Balemba, O.B., Johnson, A.C., Brooks, E.M., Zhao, H., Swain, G.M., Moses, P.L., Galligan, J.J., Sharkey, K.A., Greenwood-Van Meerveld, B., Mawe, G.M., Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology 142 (2012), 844–854 e4.
12. Mawe, G.M., Hoffman, J.M., Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol 10 (2013), 473–486.
13. Baganz, N.L., Blakely, R.D., A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci 4 (2013), 48–63.
14. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R.D., Shanahan, F., Dinan, T.G., Cryan, J.F., The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18 (2013), 666–673.
15. Winstanley, C.A., Theobald, D.E., Dalley, J.W., Glennon, J.C., Robbins, T.W., 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 176 (2004), 376–385.
16. Cools, R., Roberts, A.C., Robbins, T.W., Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 12 (2008), 31–40.
17. Wikoff, W.R., Anfora, A.T., Liu, J., Schultz, P.G., Lesley, S.A., Peters, E.C., Siuzdak, G., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106 (2009), 3698–3703.
18. Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Nagler, C.R., Ismagilov, R.F., Mazmanian, S.K., Hsiao, E.Y., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2015), 264–276.
19. Sjogren, K., Engdahl, C., Henning, P., Lerner, U.H., Tremaroli, V., Lagerquist, M.K., Backhed, F., Ohlsson, C., The gut microbiota regulates bone mass in mice. J Bone Miner Res 27 (2012), 1357–1367.
20. Hata, T., Asano, Y., Yoshihara, K., Kimura-Todani, T., Miyata, N., Zhang, X.T., Takakura, S., Aiba, Y., Koga, Y., Sudo, N., Regulation of gut luminal serotonin by commensal microbiota in mice. PLoS One, 12, 2017, e0180745.
21. Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., Dinan, T.G., The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 43 (2008), 164–174.
22. Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., Hibberd, M.L., Forssberg, H., Pettersson, S., Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 108 (2011), 3047–3052.
23. Luczynski, P., McVey Neufeld, K.A., Oriach, C.S., Clarke, G., Dinan, T.G., Cryan, J.F., Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int J Neuropsychopharmacol, 19, 2016, pyw020.
24. Luk, B., Veeraragavan, S., Engevik, M., Balderas, M., Major, A., Runge, J., Luna, R.A., Versalovic, J., Postnatal colonization with human “infant-type” Bifidobacterium species alters behavior of adult gnotobiotic mice. PLoS One, 13, 2018, e0196510.
25. Reigstad, C.S., Salmonson, C.E., Rainey, J.F. 3rd, Szurszewski, J.H., Linden, D.R., Sonnenburg, J.L., Farrugia, G., Kashyap, P.C., Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 29 (2015), 1395–1403.
26. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., Muir, A.I., Wigglesworth, M.J., Kinghorn, I., Fraser, N.J., Pike, N.B., Strum, J.C., Steplewski, K.M., Murdock, P.R., Holder, J.C., Marshall, F.H., Szekeres, P.G., Wilson, S., Ignar, D.M., Foord, S.M., Wise, A., Dowell, S.J., The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278 (2003), 11312–11319.
27. Karaki, S., Mitsui, R., Hayashi, H., Kato, I., Sugiya, H., Iwanaga, T., Furness, J.B., Kuwahara, A., Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 324 (2006), 353–360.
28. Karaki, S., Tazoe, H., Hayashi, H., Kashiwabara, H., Tooyama, K., Suzuki, Y., Kuwahara, A., Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol 39 (2008), 135–142.
29. Tazoe, H., Otomo, Y., Kaji, I., Tanaka, R., Karaki, S.I., Kuwahara, A., Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 59:Suppl 2 (2008), 251–262.
30. Nohr, M.K., Pedersen, M.H., Gille, A., Egerod, K.L., Engelstoft, M.S., Husted, A.S., Sichlau, R.M., Grunddal, K.V., Poulsen, S.S., Han, S., Jones, R.M., Offermanns, S., Schwartz, T.W., GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154 (2013), 3552–3564.
31. Martin, A.M., Lumsden, A.L., Young, R.L., Jessup, C.F., Spencer, N.J., Keating, D.J., The nutrient-sensing repertoires of mouse enterochromaffin cells differ between duodenum and colon. Neurogastroenterol Motil, 29, 2017.
32. Akiba, Y., Inoue, T., Kaji, I., Higashiyama, M., Narimatsu, K., Iwamoto, K., Watanabe, M., Guth, P.H., Engel, E., Kuwahara, A., Kaunitz, J.D., Short-chain fatty acid sensing in rat duodenum. J Physiol 593 (2015), 585–599.
33. Maruta, K., Akiba, Y., Kaji, I., Kaunitz, J.D., Serotonin released by FFA2 activation stimulates HCO3- secretion, but induces mucosal injury in rat duodenum. Gastroenterology 152 (2017), S13–S14.
34. Lin, H.V., Frassetto, A., Kowalik, E.J. Jr., Nawrocki, A.R., Lu, M.M., Kosinski, J.R., Hubert, J.A., Szeto, D., Yao, X., Forrest, G., Marsh, D.J., Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One, 7, 2012, e35240.
35. Le Poul, E., Loison, C., Struyf, S., Springael, J.Y., Lannoy, V., Decobecq, M.E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., Parmentier, M., Detheux, M., Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278 (2003), 25481–25489.
36. Tsuruta, T., Saito, S., Osaki, Y., Hamada, A., Aoki-Yoshida, A., Sonoyama, K., Organoids as an ex vivo model for studying the serotonin system in the murine small intestine and colon epithelium. Biochem Biophys Res Commun 474 (2016), 161–167.
37. O'Callaghan, A., van Sinderen, D., Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol, 7, 2016, 925.
38. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J.M., Topping, D.L., Suzuki, T., Taylor, T.D., Itoh, K., Kikuchi, J., Morita, H., Hattori, M., Ohno, H., Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 (2011), 543–547.
39. Fukuda, S., Toh, H., Taylor, T.D., Ohno, H., Hattori, M., Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3 (2012), 449–454.
40. Falony, G., Vlachou, A., Verbrugghe, K., De Vuyst, L., Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 72 (2006), 7835–7841.
41. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
42. Pokusaeva, K., Johnson, C., Luk, B., Uribe, G., Fu, Y., Oezguen, N., Matsunami, R.K., Lugo, M., Major, A., Mori-Akiyama, Y., Hollister, E.B., Dann, S.M., Shi, X.Z., Engler, D.A., Savidge, T., Versalovic, J., GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine. Neurogastroenterol Motil, 29, 2017, e12904.
43. Engevik, M.A., Morra, C.N., Roth, D., Engevik, K., Spinler, J.K., Devaraj, S., Crawford, S.E., Estes, M.K., Kalkum, M., Versalovic, J., Microbial metabolic capacity for intestinal folate production and modulation of host folate receptors. Front Microbiol, 10, 2019, 2305.
44. Chan, J.C., Kioh, D.Y., Yap, G.C., Lee, B.W., Chan, E.C., A novel LCMSMS method for quantitative measurement of short-chain fatty acids in human stool derivatized with (12)C- and (13)C-labelled aniline. J Pharm Biomed Anal 138 (2017), 43–53.
45. Engevik, M.A., Aihara, E., Montrose, M.H., Shull, G.E., Hassett, D.J., Worrell, R.T., Loss of NHE3 alters gut microbiota composition and influences Bacteroides thetaiotaomicron growth. Am J Physiol Gastrointest Liver Physiol 305 (2013), G697–G711.
46. Chang-Graham, A.L., Danhof, H.A., Engevik, M.A., Tomaro-Duchesneau, C., Karandikar, U.C., Estes, M.K., Versalovic, J., Britton, R.A., Hyser, J.M., Human intestinal enteroids with inducible neurogenin-3 expression as a novel model of gut hormone secretion. Cell Mol Gastroenterol Hepatol 8 (2019), 209–229.
47. Engevik, M.A., Danhof, H.A., Chang-Graham, A.L., Spinler, J.K., Engevik, K.A., Herrmann, B., Endres, B.T., Garey, K.W., Hyser, J.M., Britton, R.A., Versalovic, J., Human intestinal enteroids as a model of Clostridioides difficile-induced enteritis. Am J Physiol Gastrointest Liver Physiol 318 (2020), G870–G888.
48. Ruan, W., Engevik, M.A., Chang-Graham, A.L., Danhof, H.A., Goodwin, A., Engevik, K.A., Shi, Z., Hall, A., Rienzi, S.C.D., Venable, S., Britton, R.A., Hyser, J., Versalovic, J., Enhancing responsiveness of human jejunal enteroids to host and microbial stimuli. J Physiol 598 (2020), 3085–3105.
49. Saxena, K., Blutt, S.E., Ettayebi, K., Zeng, X.L., Broughman, J.R., Crawford, S.E., Karandikar, U.C., Sastri, N.P., Conner, M.E., Opekun, A.R., Graham, D.Y., Qureshi, W., Sherman, V., Foulke-Abel, J., In, J., Kovbasnjuk, O., Zachos, N.C., Donowitz, M., Estes, M.K., Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology. J Virol 90 (2016), 43–56.
50. VanDussen, K.L., Marinshaw, J.M., Shaikh, N., Miyoshi, H., Moon, C., Tarr, P.I., Ciorba, M.A., Stappenbeck, T.S., Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 64 (2015), 911–920.
51. Ettayebi, K., Crawford, S.E., Murakami, K., Broughman, J.R., Karandikar, U., Tenge, V.R., Neill, F.H., Blutt, S.E., Zeng, X.L., Qu, L., Kou, B., Opekun, A.R., Burrin, D., Graham, D.Y., Ramani, S., Atmar, R.L., Estes, M.K., Replication of human noroviruses in stem cell-derived human enteroids. Science 353 (2016), 1387–1393.
52. Foulke-Abel, J., In, J., Kovbasnjuk, O., Zachos, N.C., Ettayebi, K., Blutt, S.E., Hyser, J.M., Zeng, X.L., Crawford, S.E., Broughman, J.R., Estes, M.K., Donowitz, M., Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract. Exp Biol Med (Maywood) 239 (2014), 1124–1134.
53. Foulke-Abel, J., In, J., Yin, J., Zachos, N.C., Kovbasnjuk, O., Estes, M.K., de Jonge, H., Donowitz, M., Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology. Gastroenterology 150 (2016), 638–649 e8.
54. Saxena, K., Simon, L.M., Zeng, X.L., Blutt, S.E., Crawford, S.E., Sastri, N.P., Karandikar, U.C., Ajami, N.J., Zachos, N.C., Kovbasnjuk, O., Donowitz, M., Conner, M.E., Shaw, C.A., Estes, M.K., A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc Natl Acad Sci U S A 114 (2017), E570–E579.
55. Zachos, N.C., Kovbasnjuk, O., Foulke-Abel, J., In, J., Blutt, S.E., de Jonge, H.R., Estes, M.K., Donowitz, M., Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J Biol Chem 291 (2016), 3759–3766.
56. Zou, W.Y., Blutt, S.E., Crawford, S.E., Ettayebi, K., Zeng, X.L., Saxena, K., Ramani, S., Karandikar, U.C., Zachos, N.C., Estes, M.K., Human intestinal enteroids: new models to study gastrointestinal virus infections. Methods Mol Biol 1576 (2019), 229–247.
57. Endres, B., Basseres, E., Rashid, T., Chang, L., Alam, M.J., Garey, K.W., A protocol to characterize the morphological changes of Clostridium difficile in response to antibiotic treatment. J Vis Exp, 123, 2017, 55383.
58. Langendijk, P.S., Schut, F., Jansen, G.J., Raangs, G.C., Kamphuis, G.R., Wilkinson, M.H., Welling, G.W., Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61 (1995), 3069–3075.
59. Engevik, M.A., Engevik, K.A., Yacyshyn, M.B., Wang, J., Hassett, D.J., Darien, B., Yacyshyn, B.R., Worrell, R.T., Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile. Am J Physiol Gastrointest Liver Physiol 308 (2015), G497–G509.
60. Engevik, M.A., Yacyshyn, M.B., Engevik, K.A., Wang, J., Darien, B., Hassett, D.J., Yacyshyn, B.R., Worrell, R.T., Human Clostridium difficile infection: altered mucus production and composition. Am J Physiol Gastrointest Liver Physiol 308 (2015), G510–G524.
61. Wang, Y.M., Ge, X.Z., Wang, W.Q., Wang, T., Cao, H.L., Wang, B.L., Wang, B.M., Lactobacillus rhamnosus GG supernatant upregulates serotonin transporter expression in intestinal epithelial cells and mice intestinal tissues. Neurogastroenterol Motil 27 (2015), 1239–1248.
62. Franich, N.R., Fitzsimons, H.L., Fong, D.M., Klugmann, M., During, M.J., Young, D., AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. Mol Ther 16 (2008), 947–956.
63. Miyamoto, Y., Watanabe, K., Tanaka, R., Itoh, K., Distribution analysis of six predominant Bacteroides species in normal human feces using 16S rDNA-targeted species-specific primers. Microbial Ecol Health Dis 14 (2002), 133–136.
64. Li, Z., Chalazonitis, A., Huang, Y.Y., Mann, J.J., Margolis, K.G., Yang, Q.M., Kim, D.O., Cote, F., Mallet, J., Gershon, M.D., Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci 31 (2011), 8998–9009.
65. Carson, J.P., Eichele, G., Chiu, W., A method for automated detection of gene expression required for the establishment of a digital transcriptome-wide gene expression atlas. J Microsc 217 (2005), 275–281.
66. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Codelli, J.A., Chow, J., Reisman, S.E., Petrosino, J.F., Patterson, P.H., Mazmanian, S.K., Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
67. Deacon, R.M., Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc 1 (2006), 122–124.
68. Angoa-Perez, M., Kane, M.J., Briggs, D.I., Francescutti, D.M., Kuhn, D.M., Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J Vis Exp, 82, 2013, 50978.
69. Wertman, V., Gromova, A., La Spada, A.R., Cortes, C.J., Low-cost gait analysis for behavioral phenotyping of mouse models of neuromuscular disease. J Vis Exp, 149, 2019.
70. Heck, D.H., Zhao, Y., Roy, S., LeDoux, M.S., Reiter, L.T., Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors. Hum Mol Genet 17 (2008), 2181–2189.
71. Stanley, J.L., Lincoln, R.J., Brown, T.A., McDonald, L.M., Dawson, G.R., Reynolds, D.S., The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines. J Psychopharmacol 19 (2005), 221–227.
72. Ventura, M., Turroni, F., Zomer, A., Foroni, E., Giubellini, V., Bottacini, F., Canchaya, C., Claesson, M.J., He, F., Mantzourani, M., Mulas, L., Ferrarini, A., Gao, B., Delledonne, M., Henrissat, B., Coutinho, P., Oggioni, M., Gupta, R.S., Zhang, Z., Beighton, D., Fitzgerald, G.F., O'Toole, P.W., van Sinderen, D., The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity. PLoS Genet, 5, 2009, e1000785.
73. Bellono, N.W., Bayrer, J.R., Leitch, D.B., Castro, J., Zhang, C., O'Donnell, T.A., Brierley, S.M., Ingraham, H.A., Julius, D., Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell 170 (2017), 185–198 e16.
74. Bertrand, P.P., Bertrand, R.L., Serotonin release and uptake in the gastrointestinal tract. Auton Neurosci 153 (2010), 47–57.
75. Linan-Rico, A., Ochoa-Cortes, F., Beyder, A., Soghomonyan, S., Zuleta-Alarcon, A., Coppola, V., Christofi, F.L., Mechanosensory signaling in enterochromaffin cells and 5-HT release: potential implications for gut inflammation. Front Neurosci, 10, 2016, 564.
76. Lund, M.L., Egerod, K.L., Engelstoft, M.S., Dmytriyeva, O., Theodorsson, E., Patel, B.A., Schwartz, T.W., Enterochromaffin 5-HT cells - a major target for GLP-1 and gut microbial metabolites. Mol Metab 11 (2018), 70–83.
77. Kushnir-Sukhov, N.M., Brown, J.M., Wu, Y., Kirshenbaum, A., Metcalfe, D.D., Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol 119 (2007), 498–499.
78. Ringvall, M., Ronnberg, E., Wernersson, S., Duelli, A., Henningsson, F., Abrink, M., Garcia-Faroldi, G., Fajardo, I., Pejler, G., Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan. J Allergy Clin Immunol 121 (2008), 1020–1026.
79. Cote, F., Thevenot, E., Fligny, C., Fromes, Y., Darmon, M., Ripoche, M.A., Bayard, E., Hanoun, N., Saurini, F., Lechat, P., Dandolo, L., Hamon, M., Mallet, J., Vodjdani, G., Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A 100 (2003), 13525–13530.
80. Walther, D.J., Peter, J.U., Bashammakh, S., Hortnagl, H., Voits, M., Fink, H., Bader, M., Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299, 2003, 76.
81. Khailova, L., Mount Patrick, S.K., Arganbright, K.M., Halpern, M.D., Kinouchi, T., Dvorak, B., Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299 (2010), G1118–G1127.
82. Hughes, K.R., Harnisch, L.C., Alcon-Giner, C., Mitra, S., Wright, C.J., Ketskemety, J., van Sinderen, D., Watson, A.J., Hall, L.J., Bifidobacterium breve reduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner. Open Biol, 7, 2017, 160155.
83. Apelqvist, A., Li, H., Sommer, L., Beatus, P., Anderson, D.J., Honjo, T., Hrabe de Angelis, M., Lendahl, U., Edlund, H., Notch signalling controls pancreatic cell differentiation. Nature 400 (1999), 877–881.
84. Gradwohl, G., Dierich, A., LeMeur, M., Guillemot, F., Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 97 (2000), 1607–1611.
85. Jenny, M., Uhl, C., Roche, C., Duluc, I., Guillermin, V., Guillemot, F., Jensen, J., Kedinger, M., Gradwohl, G., Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 21 (2002), 6338–6347.
86. Jensen, J., Heller, R.S., Funder-Nielsen, T., Pedersen, E.E., Lindsell, C., Weinmaster, G., Madsen, O.D., Serup, P., Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes 49 (2000), 163–176.
87. Neufeld, K.M., Kang, N., Bienenstock, J., Foster, J.A., Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 23 (2011), 255–264 e119.
88. Nishino, R., Mikami, K., Takahashi, H., Tomonaga, S., Furuse, M., Hiramoto, T., Aiba, Y., Koga, Y., Sudo, N., Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol Motil 25 (2013), 521–528.
89. Neufeld, K.A., Kang, N., Bienenstock, J., Foster, J.A., Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol 4 (2011), 492–494.
90. Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T.G., Cryan, J.F., Microbiota is essential for social development in the mouse. Mol Psychiatry 19 (2014), 146–148.
91. Honda, S., Kawaura, K., Soeda, F., Shirasaki, T., Takahama, K., The potent inhibitory effect of tipepidine on marble-burying behavior in mice. Behav Brain Res 216 (2011), 308–312.
92. Broekkamp, C.L., Rijk, H.W., Joly-Gelouin, D., Lloyd, K.L., Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur J Pharmacol 126 (1986), 223–229.
93. Ichimaru, Y., Egawa, T., Sawa, A., 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 68 (1995), 65–70.
94. Takeuchi, H., Yatsugi, S., Yamaguchi, T., Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model. Jpn J Pharmacol 90 (2002), 197–200.
95. Li, X., Morrow, D., Witkin, J.M., Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying. Life Sci 78 (2006), 1933–1939.
96. Nicolas, L.B., Kolb, Y., Prinssen, E.P., A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur J Pharmacol 547 (2006), 106–115.
97. Kim, M., Cooke, H.J., Javed, N.H., Carey, H.V., Christofi, F., Raybould, H.E., D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology 121 (2001), 1400–1406.
98. Haugen, M., Dammen, R., Svejda, B., Gustafsson, B.I., Pfragner, R., Modlin, I., Kidd, M., Differential signal pathway activation and 5-HT function: the role of gut enterochromaffin cells as oxygen sensors. Am J Physiol Gastrointest Liver Physiol 303 (2012), G1164–G1173.
99. Zelkas, L., Raghupathi, R., Lumsden, A.L., Martin, A.M., Sun, E., Spencer, N.J., Young, R.L., Keating, D.J., Serotonin-secreting enteroendocrine cells respond via diverse mechanisms to acute and chronic changes in glucose availability. Nutr Metab (Lond), 12, 2015, 55.
100. Essand, M., Vikman, S., Grawe, J., Gedda, L., Hellberg, C., Oberg, K., Totterman, T.H., Giandomenico, V., Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1. J Mol Endocrinol 35 (2005), 489–501.
101. Nozawa, K., Kawabata-Shoda, E., Doihara, H., Kojima, R., Okada, H., Mochizuki, S., Sano, Y., Inamura, K., Matsushime, H., Koizumi, T., Yokoyama, T., Ito, H., TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci U S A 106 (2009), 3408–3413.
102. Schafermeyer, A., Gratzl, M., Rad, R., Dossumbekova, A., Sachs, G., Prinz, C., Isolation and receptor profiling of ileal enterochromaffin cells. Acta Physiol Scand 182 (2004), 53–62.
103. Fukumoto, S., Tatewaki, M., Yamada, T., Fujimiya, M., Mantyh, C., Voss, M., Eubanks, S., Harris, M., Pappas, T.N., Takahashi, T., Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol 284 (2003), R1269–R1276.
104. Esmaili, A., Nazir, S.F., Borthakur, A., Yu, D., Turner, J.R., Saksena, S., Singla, A., Hecht, G.A., Alrefai, W.A., Gill, R.K., Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. Gastroenterology 137 (2009), 2074–2083.
105. Nzakizwanayo, J., Dedi, C., Standen, G., Macfarlane, W.M., Patel, B.A., Jones, B.V., Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance. Sci Rep, 5, 2015, 17324.
106. Bogunovic, M., Dave, S.H., Tilstra, J.S., Chang, D.T., Harpaz, N., Xiong, H., Mayer, L.F., Plevy, S.E., Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol 292 (2007), G1770–G1783.
107. Nakaita, Y., Kaneda, H., Shigyo, T., Heat-killed Lactobacillus brevis SBC8803 induces serotonin release from intestinal cells. Food Nutr Sci 4 (2013), 767–771.
108. Roy, D., Ward, P., Rapid detection of Bifidobacterium dentium by enzymatic hydrolysis of β-glucuronide substrates. J Food Protect 55 (1992), 291–295.
109. Fujimiya, M., Okumiya, K., Kuwahara, A., Immunoelectron microscopic study of the luminal release of serotonin from rat enterochromaffin cells induced by high intraluminal pressure. Histochem Cell Biol 108 (1997), 105–113.
110. Patel, B.A., Bian, X., Quaiserova-Mocko, V., Galligan, J.J., Swain, G.M., In vitro continuous amperometric monitoring of 5-hydroxytryptamine release from enterochromaffin cells of the guinea pig ileum. Analyst 132 (2007), 41–47.
111. Bertrand, P.P., Hu, X., Mach, J., Bertrand, R.L., Serotonin (5-HT) release and uptake measured by real-time electrochemical techniques in the rat ileum. Am J Physiol Gastrointest Liver Physiol 295 (2008), G1228–G1236.
112. Ahlman, H., Bhargava, H.N., Dahlstrom, A., Larsson, I., Newson, B., Pettersson, G., On the presence of serotonin in the gut lumen and possible release mechanisms. Acta Physiol Scand 112 (1981), 263–269.
113. Forsberg, E.J., Miller, R.J., Cholinergic agonists induce vectorial release of serotonin from duodenal enterochromaffin cells. Science 217 (1982), 355–356.
114. Fujimiya, M., Yamamoto, H., Kuwahara, A., Effect of VIP and PACAP on vascular and luminal release of serotonin from isolated perfused rat duodenum. Ann N Y Acad Sci 865 (1998), 495–502.
115. Tsukamoto, K., Ariga, H., Mantyh, C., Pappas, T.N., Yanagi, H., Yamamura, T., Takahashi, T., Luminally released serotonin stimulates colonic motility and accelerates colonic transit in rats. Am J Physiol Regul Integr Comp Physiol 293 (2007), R64–R69.
116. Oleskin, A.V., Kirovskaia, T.A., Botvinko, I.V., Lysak, L.V., [Effect of serotonin (5-hydroxytryptamine) on the growth and differentiation of microorganisms]. Mikrobiologiia 67 (1998), 305–312.
117. Tsavkelova, E.A., Klimova, S., Cherdyntseva, T.A., Netrusov, A.I., [Hormones and hormone-like substances of microorganisms: a review]. Prikl Biokhim Mikrobiol 42 (2006), 261–268.
118. Knecht, L.D., O'Connor, G., Mittal, R., Liu, X.Z., Daftarian, P., Deo, S.K., Daunert, S., Serotonin activates bacterial quorum sensing and enhances the virulence of Pseudomonas aeruginosa in the host. EBioMedicine 9 (2016), 161–169.
119. Rios-Covian, D., Gueimonde, M., Duncan, S.H., Flint, H.J., de los Reyes-Gavilan, C.G., Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett, 362, 2015, fnv176.
120. Turroni, F., Milani, C., Duranti, S., Mahony, J., van Sinderen, D., Ventura, M., Glycan utilization and cross-feeding activities by Bifidobacteria. Trends Microbiol 26 (2018), 339–350.
121. Spencer, N.J., Nicholas, S.J., Robinson, L., Kyloh, M., Flack, N., Brookes, S.J., Zagorodnyuk, V.P., Keating, D.J., Mechanisms underlying distension-evoked peristalsis in guinea pig distal colon: is there a role for enterochromaffin cells?. Am J Physiol Gastrointest Liver Physiol 301 (2011), G519–G527.
122. Heredia, D.J., Gershon, M.D., Koh, S.D., Corrigan, R.D., Okamoto, T., Smith, T.K., Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes: in vitro analyses in mice lacking tryptophan hydroxylase 1. J Physiol 591 (2013), 5939–5957.
123. Bercik, P., Park, A.J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., Deng, Y., Blennerhassett, P.A., Fahnestock, M., Moine, D., Berger, B., Huizinga, J.D., Kunze, W., McLean, P.G., Bergonzelli, G.E., Collins, S.M., Verdu, E.F., The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23 (2011), 1132–1139.
124. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.F., Rougeot, C., Pichelin, M., Cazaubiel, M., Cazaubiel, J.M., Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 105 (2011), 755–764.
125. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J.F., Dinan, T.G., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (2010), 1179–1188.
126. Pinto-Sanchez, M.I., Hall, G.B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J.T., Martin, F.P., Cominetti, O., Welsh, C., Rieder, A., Traynor, J., Gregory, C., De Palma, G., Pigrau, M., Ford, A.C., Macri, J., Berger, B., Bergonzelli, G., Surette, M.G., Collins, S.M., Moayyedi, P., Bercik, P., Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology 153 (2017), 448–459 e8.
127. Luck, B., Engevik, M.A., Ganesh, B.P., Lackey, E.P., Lin, T., Balderas, M., Major, A., Runge, J., Luna, R.A., Sillitoe, R.V., Versalovic, J., Bifidobacteria shape host neural circuits during postnatal development by promoting synapse formation and microglial function. Sci Rep, 10, 2020, 7737.
128. Sachs, B.D., Rodriguiz, R.M., Siesser, W.B., Kenan, A., Royer, E.L., Jacobsen, J.P., Wetsel, W.C., Caron, M.G., The effects of brain serotonin deficiency on behavioural disinhibition and anxiety-like behaviour following mild early life stress. Int J Neuropsychopharmacol 16 (2013), 2081–2094.
129. Fossat, P., Bacque-Cazenave, J., De Deurwaerdere, P., Cattaert, D., Delbecque, J.P., Serotonin, but not dopamine, controls the stress response and anxiety-like behavior in the crayfish Procambarus clarkii. J Exp Biol 218 (2015), 2745–2752.
130. Fossat, P., Bacque-Cazenave, J., De Deurwaerdere, P., Delbecque, J.P., Cattaert, D., Comparative behavior. Anxiety-like behavior in crayfish is controlled by serotonin. Science 344 (2014), 1293–1297.
131. Heisler, L.K., Zhou, L., Bajwa, P., Hsu, J., Tecott, L.H., Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav 6 (2007), 491–496.
132. Xiang, M., Jiang, Y., Hu, Z., Yang, Y., Botchway, B.O.A., Fang, M., Stimulation of anxiety-like behavior via ERK pathway by competitive serotonin receptors 2A and 1A in post-traumatic stress disordered mice. Neurosignals 25 (2017), 39–53.
133. Holmes, A., Lit, Q., Murphy, D.L., Gold, E., Crawley, J.N., Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2 (2003), 365–380.
134. Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., Kubo, C., Koga, Y., Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558 (2004), 263–275.
135. Ramamoorthy, S., Cool, D.R., Mahesh, V.B., Leibach, F.H., Melikian, H.E., Blakely, R.D., Ganapathy, V., Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J Biol Chem 268 (1993), 21626–21631.
136. Guiard, B.P., Di Giovanni, G., Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?. Front Pharmacol, 6, 2015, 46.
137. Weisstaub, N.V., Zhou, M., Lira, A., Lambe, E., Gonzalez-Maeso, J., Hornung, J.P., Sibille, E., Underwood, M., Itohara, S., Dauer, W.T., Ansorge, M.S., Morelli, E., Mann, J.J., Toth, M., Aghajanian, G., Sealfon, S.C., Hen, R., Gingrich, J.A., Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313 (2006), 536–540.
138. Lee, J.Y., Jeon, B.S., Kim, H.J., Park, S.S., Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease. Parkinsonism Relat Disord 18 (2012), 76–78.
139. Borovikova, L.V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G.I., Watkins, L.R., Wang, H., Abumrad, N., Eaton, J.W., Tracey, K.J., Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000), 458–462.
140. Wang, X., Wang, B.R., Zhang, X.J., Xu, Z., Ding, Y.Q., Ju, G., Evidences for vagus nerve in maintenance of immune balance and transmission of immune information from gut to brain in STM-infected rats. World J Gastroenterol 8 (2002), 540–545.
141. Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K.D., Verdu, E.F., Collins, S.M., The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141 (2011), 599–609 e1-3.
142. Verdu, E.F., Bercik, P., Verma-Gandhu, M., Huang, X.X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., Collins, S.M., Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55 (2006), 182–190.
143. Carabotti, M., Scirocco, A., Maselli, M.A., Severi, C., The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28 (2015), 203–209.
144. Kunze, W.A., Mao, Y.K., Wang, B., Huizinga, J.D., Ma, X., Forsythe, P., Bienenstock, J., Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med 13 (2009), 2261–2270.
145. Iyer, L.M., Aravind, L., Coon, S.L., Klein, D.C., Koonin, E.V., Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role?. Trends Genet 20 (2004), 292–299.
146. Arentsen, T., Qian, Y., Gkotzis, S., Femenia, T., Wang, T., Udekwu, K., Forssberg, H., Diaz Heijtz, R., The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. Mol Psychiatry 22 (2017), 257–266.
147. O'Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O'Sullivan, G.C., Kiely, B., Collins, J.K., Shanahan, F., Quigley, E.M., Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128 (2005), 541–551.
148. Guglielmetti, S., Mora, D., Gschwender, M., Popp, K., Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther 33 (2011), 1123–1132.
149. O'Sullivan, M.A., O'Morain, C.A., Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 32 (2000), 294–301.
150. Zocco, M.A., dal Verme, L.Z., Cremonini, F., Piscaglia, A.C., Nista, E.C., Candelli, M., Novi, M., Rigante, D., Cazzato, I.A., Ojetti, V., Armuzzi, A., Gasbarrini, G., Gasbarrini, A., Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 23 (2006), 1567–1574.
151. Oliva, S., Di Nardo, G., Ferrari, F., Mallardo, S., Rossi, P., Patrizi, G., Cucchiara, S., Stronati, L., Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 35 (2012), 327–334.
152. Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., Otsuka, M., Hasunuma, O., Kurihara, R., Iwasaki, A., Arakawa, Y., Randomized placebo-controlled trial assessing the effect of Bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 20 (2004), 1133–1141.